Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
25 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250625821763/en/Precision-BioSciences-Receives-FDA-Rare-Pediatric-Disease-Designation-for-PBGENE-DMD-for-the-Treatment-of-Duchenne-Muscular-Dystrophy
15 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250515965645/en/Precision-BioSciences-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update
14 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250514900148/en/Precision-BioSciences-Accelerates-Development-of-PBGENE-DMD-Within-its-Wholly-Owned-Organic-Pipeline-and-Highlights-Pre-clinical-Evidence-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-Annual-Meeting
08 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250508234714/en/Precision-BioSciences-to-Report-First-Quarter-2025-Results-on-May-15-2025
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507539035/en/Precision-BioSciences-Announces-Presentation-of-Initial-Safety-Data-from-the-Phase-1-ELIMINATE-B-Trial-Evaluating-PBGENE-HBV-at-the-2025-European-Association-for-the-Study-of-the-Liver-Congress-EASL
01 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250501903476/en/Precision-BioSciences-Announces-Multiple-Presentations-for-In-Vivo-Gene-Editing-Programs-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-Annual-Meeting
ABOUT THIS PAGE